Follow
David Pitt
David Pitt
Associate Professor, Yale
Verified email at yale.edu
Title
Cited by
Cited by
Year
Glutamate excitotoxicity in a model of multiple sclerosis
D Pitt, P Werner, CS Raine
Nature medicine 6 (1), 67-70, 2000
10712000
Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage
P Werner, D Pitt, CS Raine
Annals of neurology 50 (2), 169-180, 2001
6012001
B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes
JNH Stern, G Yaari, JA Vander Heiden, G Church, WF Donahue, ...
Science translational medicine 6 (248), 248ra107-248ra107, 2014
4522014
Mental representation
D Pitt
4302000
The role of astrocytes in multiple sclerosis
G Ponath, C Park, D Pitt
Frontiers in immunology 9, 337102, 2018
3262018
Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis
D Pitt, IE Nagelmeier, HC Wilson, CS Raine
Neurology 61 (8), 1113-1120, 2003
2852003
Clinical quantitative susceptibility mapping (QSM): biometal imaging and its emerging roles in patient care
Y Wang, P Spincemaille, Z Liu, A Dimov, K Deh, J Li, Y Zhang, Y Yao, ...
Journal of magnetic resonance imaging 46 (4), 951-971, 2017
2692017
Quantitative susceptibility mapping (QSM) of white matter multiple sclerosis lesions: interpreting positive susceptibility and the presence of iron
C Wisnieff, S Ramanan, J Olesik, S Gauthier, Y Wang, D Pitt
Magnetic resonance in medicine 74 (2), 564-570, 2015
2642015
Quantitative susceptibility mapping of multiple sclerosis lesions at various ages
W Chen, SA Gauthier, A Gupta, J Comunale, T Liu, S Wang, M Pei, D Pitt, ...
Radiology 271 (1), 183-192, 2014
2582014
Imaging cortical lesions in multiple sclerosis with ultra–high-field magnetic resonance imaging
D Pitt, A Boster, W Pei, E Wohleb, A Jasne, CR Zachariah, K Rammohan, ...
Archives of neurology 67 (7), 812-818, 2010
2332010
Biomarkers in multiple sclerosis
WJ Housley, D Pitt, DA Hafler
Clinical immunology 161 (1), 51-58, 2015
2202015
Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions
V Mehta, W Pei, G Yang, S Li, E Swamy, A Boster, P Schmalbrock, D Pitt
PloS one 8 (3), e57573, 2013
2172013
Myelin phagocytosis by astrocytes after myelin damage promotes lesion pathology
G Ponath, S Ramanan, M Mubarak, W Housley, S Lee, FR Sahinkaya, ...
Brain 140 (2), 399-413, 2017
1912017
Experimental autoimmune encephalomyelitis (EAE) in CCR2−/− mice: susceptibility in multiple strains
S Gaupp, D Pitt, WA Kuziel, B Cannella, CS Raine
The American journal of pathology 162 (1), 139-150, 2003
1912003
Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions
UW Kaunzner, Y Kang, S Zhang, E Morris, Y Yao, S Pandya, ...
Brain 142 (1), 133-145, 2019
1632019
Iron in multiple sclerosis and its noninvasive imaging with quantitative susceptibility mapping
C Stüber, D Pitt, Y Wang
International journal of molecular sciences 17 (1), 100, 2016
1132016
Macrophage migration inhibitory factor potentiates autoimmune-mediated neuroinflammation
GM Cox, AP Kithcart, D Pitt, Z Guan, J Alexander, JL Williams, T Shawler, ...
The Journal of Immunology 191 (3), 1043-1054, 2013
1072013
Glutamate excitotoxicity—a mechanism for axonal damage and oligodendrocyte death in multiple sclerosis?
P Werner, D Pitt, CS Raine
Advances in Research on Neurodegeneration, 375-385, 2000
1072000
Insulin-like growth factor-1 fails to enhance central nervous system myelin repair during autoimmune demyelination
B Cannella, D Pitt, E Capello, CS Raine
The American journal of pathology 157 (3), 933-943, 2000
992000
Neuregulin and erbB receptor expression in normal and diseased human white matter
B Cannella, D Pitt, M Marchionni, CS Raine
Journal of Neuroimmunology 100 (1-2), 233-242, 1999
911999
The system can't perform the operation now. Try again later.
Articles 1–20